These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19059378)

  • 21. Effects of LPS, lipid A and polysaccharide from adapted strains of Escherichia coli on human leucocyte activity.
    Koscová H; Dubnicková M; Bukovský M; Mlynarcík D
    Pharmazie; 2008 Feb; 63(2):147-50. PubMed ID: 18380402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of the lipopolysaccharide core of Vibrio vulnificus type strain 27562.
    Vinogradov E; Wilde C; Anderson EM; Nakhamchik A; Lam JS; Rowe-Magnus DA
    Carbohydr Res; 2009 Mar; 344(4):484-90. PubMed ID: 19185290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Both LCCL-domains of human CRISPLD2 have high affinity for lipid A.
    Vásárhelyi V; Trexler M; Patthy L
    Biochimie; 2014 Feb; 97():66-71. PubMed ID: 24090571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble CD14 in periodontitis.
    Nicu EA; Laine ML; Morré SA; Van der Velden U; Loos BG
    Innate Immun; 2009 Apr; 15(2):121-8. PubMed ID: 19318422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for endotoxic and antagonistic activities: investigation with novel synthetic lipid A analogs.
    Kusumoto S; Fukase K; Fukase Y; Kataoka M; Yoshizaki H; Sato K; Oikawa M; Suda Y
    J Endotoxin Res; 2003; 9(6):361-6. PubMed ID: 14733722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure/function relationships of CD14.
    Stelter F
    Chem Immunol; 2000; 74():25-41. PubMed ID: 10608080
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of lipopolysaccharide from a heptoseless mutant of Escherichia coli by carbon 13 nuclear magnetic resonance.
    Strain SM; Fesik SW; Armitage IM
    J Biol Chem; 1983 Mar; 258(5):2906-10. PubMed ID: 6338007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural investigations into the interaction of hemoglobin and part structures with bacterial endotoxins.
    Howe J; Garidel P; Roessle M; Richter W; Alexander C; Fournier K; Mach JP; Waelli T; Gorczynski RM; Ulmer AJ; Zähringer U; Hartmann A; Rietschel ET; Brandenburg K
    Innate Immun; 2008 Feb; 14(1):39-49. PubMed ID: 18387918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMR structure of rALF-Pm3, an anti-lipopolysaccharide factor from shrimp: model of the possible lipid A-binding site.
    Yang Y; Boze H; Chemardin P; Padilla A; Moulin G; Tassanakajon A; Pugnière M; Roquet F; Destoumieux-Garzón D; Gueguen Y; Bachère E; Aumelas A
    Biopolymers; 2009 Mar; 91(3):207-20. PubMed ID: 19107926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetraspanin CD9 negatively regulates lipopolysaccharide-induced macrophage activation and lung inflammation.
    Suzuki M; Tachibana I; Takeda Y; He P; Minami S; Iwasaki T; Kida H; Goya S; Kijima T; Yoshida M; Kumagai T; Osaki T; Kawase I
    J Immunol; 2009 May; 182(10):6485-93. PubMed ID: 19414803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete structure of lipid A obtained from the lipopolysaccharides of the heptoseless mutant of Salmonella typhimurium.
    Takayama K; Qureshi N; Mascagni P
    J Biol Chem; 1983 Nov; 258(21):12801-3. PubMed ID: 6355095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic peptides representing the N-terminal segment of surfactant protein C modulate LPS-stimulated TNF-alpha production by macrophages.
    Garcia-Verdugo I; Garcia de Paco E; Espinassous Q; Gonzalez-Horta A; Synguelakis M; Kanellopoulos J; Rivas L; Chaby R; Perez-Gil J
    Innate Immun; 2009 Feb; 15(1):53-62. PubMed ID: 19201825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of the first cis-cyclobutane-containing receptor for lipid A.
    Bucholtz KM; Gareiss PC; Tajc SG; Miller BL
    Org Biomol Chem; 2006 Nov; 4(21):3973-9. PubMed ID: 17047878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure and dynamics of 13C,15N-labeled lipopolysaccharides in a membrane mimetic.
    Wang W; Sass HJ; Zähringer U; Grzesiek S
    Angew Chem Int Ed Engl; 2008; 47(51):9870-4. PubMed ID: 19034945
    [No Abstract]   [Full Text] [Related]  

  • 35. Novel strategies to overcome expression problems encountered with toxic proteins: application to the production of Lac repressor proteins for NMR studies.
    Romanuka J; van den Bulke H; Kaptein R; Boelens R; Folkers GE
    Protein Expr Purif; 2009 Oct; 67(2):104-12. PubMed ID: 19460439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemical characteristics and endotoxic activity of the lipopolysaccharide of Rahnella aquatilis 2-95].
    Varbanets LD; Zdorovenko EL; Ostapchuk AN
    Mikrobiologiia; 2008; 77(3):342-9. PubMed ID: 18683651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear magnetic resonance of lipid A--the influence of solvents on spin relaxation and spectral quality.
    Brecker L
    Chem Phys Lipids; 2003 Sep; 125(1):27-39. PubMed ID: 14625073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New data on the chemical structure of lipopolysaccharides and the practical prospects].
    Iarovaia LM; Aleshkin VA
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Mar; (3):73-8. PubMed ID: 1872103
    [No Abstract]   [Full Text] [Related]  

  • 39. Altered hepatic inflammatory response in the offspring following prenatal LPS exposure.
    Surriga O; Ortega A; Jadeja V; Bellafronte A; Lasala N; Zhou H
    Immunol Lett; 2009 Mar; 123(1):88-95. PubMed ID: 19428555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of lysozyme to synthetic monosaccharide lipid A analogue, GLA60.
    Tanida N; Onho N; Adachi Y; Matsuura M; Nakano M; Kiso M; Hasegawa A; Yadomae T
    Biol Pharm Bull; 1993 Mar; 16(3):288-92. PubMed ID: 8364474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.